Results 1 to 10 of about 789,141 (218)
Some of the next articles are maybe not open access.

Sclerostin and Dickkopf-1 as Therapeutic Targets in Bone Diseases

Endocrine Reviews, 2012
Hua Zhu Ke   +2 more
exaly  

Mesenchymal Stem Cell Migration during Bone Formation and Bone Diseases Therapy

International Journal of Molecular Sciences, 2018
Peihong Su, Ye Tian, Jiawei Pei
exaly  

Pathology: Diseases of Bone

New England Journal of Medicine, 1956
Louis Lichtenstein
exaly  

Progress in oral biomaterials for the treatment of metabolic bone diseases

Progress in Materials Science
Yunkai Tang, Wenguo Cui
exaly  

Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration

International Journal of Nanomedicine, 2013
Yin Xiao, Wenyi Gu, Chengtie Wu
exaly  

Age-related bone diseases: Role of inflammaging

Journal of Autoimmunity
Jiaming Bi, Chuzi Mo, Mingyan Yao
exaly  

Involvement of ICAM-1 in bone metabolism: a potential target in the treatment of bone diseases?

Expert Opinion on Biological Therapy, 2005
Patrick Lavigne   +2 more
exaly  

Necrostatin-1 Alleviates Diffuse Pulmonary Haemorrhage by Preventing the Release of NETs via Inhibiting NE/GSDMD Activation in Murine Lupus

open access: yesJournal of Immunology Research, 2023
Diffuse alveolar haemorrhage (DAH) is a rapidly developing condition owing to a lack of effective treatment and resulting in a high mortality rate in systemic lupus erythematosus (SLE).
Xinai Han   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy